Although ARID1A mutations are a primary cause of ARID1A protein loss in ~10–15% of CRC patients, other mechanisms- such as epigenetic regulation and microRNAs-mediated repression- also contribute to ARID1A downregulation [8, 51]. Here, ARID1A is linked to colorectal carcinoma.